| Literature DB >> 28585318 |
Martin de Boer1, Karin van Leeuwen1, Judy Geissler1, Floris van Alphen1, Esther de Vries2, Martijn van der Kuip3, Suzanne W J Terheggen4, Hans Janssen5, Timo K van den Berg1, Alexander B Meijer1, Dirk Roos1, Taco W Kuijpers1,6.
Abstract
Hermansky-Pudlak syndrome type 2 (HPS2) is a syndrome caused by mutations in the beta-3A subunit of the adaptor protein (AP)-3 complex (AP3B1 gene). We describe five unreported cases with four novel mutations, one of which caused aberrant pre-mRNA splicing. A point mutation c.2702C>G in exon 23 of the AP3B1 gene caused deletion of 112 bp in the mRNA in two siblings. This mutation activates a cryptic donor splice site that overrules the wild-type donor splice site of this exon. Three other novel mutations in AP3B1 were identified, that is, a nonsense mutation c.716G>A (p.Trp239Ter), a 1-bp and a 4-bp deletion c.177delA and c.1839_1842delTAGA, respectively, both causing frameshift and premature termination of translation. Mass spectrometry in four of these HPS2 patients demonstrated the (near) absence of all AP-3 complex subunits. Immunoelectron microscopy on the neutrophils of two of these patients showed abnormal granule formation. We found clear mislocalization of myeloperoxidase in the neutrophils even though the content of this protein but not the activity seemed to be present at normal levels. In sum, HPS2 is the result of the absence of the entire AP-3 complex, which results in severe neutropenia with a defect in granule formation as the major hematological finding.Entities:
Keywords: AP3B1; Hermansky-Pudlak syndrome; cryptic splice site; neutrophil granule formation; pre-mRNA splicing
Mesh:
Substances:
Year: 2017 PMID: 28585318 DOI: 10.1002/humu.23271
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878